NM_000489.6:c.4359_4361delGGA

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP3BP6BS2

The NM_000489.6(ATRX):​c.4359_4361delGGA​(p.Glu1454del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000059 in 1,202,608 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E1453E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.000060 ( 0 hom. 20 hem. )

Consequence

ATRX
NM_000489.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 2.14

Publications

0 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000489.6
BP6
Variant X-77652309-TTCC-T is Benign according to our data. Variant chrX-77652309-TTCC-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 533623.
BS2
High Hemizygotes in GnomAdExome4 at 20 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
NM_000489.6
MANE Select
c.4359_4361delGGAp.Glu1454del
disruptive_inframe_deletion
Exon 15 of 35NP_000480.3
ATRX
NM_138270.5
c.4245_4247delGGAp.Glu1416del
disruptive_inframe_deletion
Exon 14 of 34NP_612114.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
ENST00000373344.11
TSL:1 MANE Select
c.4359_4361delGGAp.Glu1454del
disruptive_inframe_deletion
Exon 15 of 35ENSP00000362441.4
ATRX
ENST00000395603.7
TSL:1
c.4245_4247delGGAp.Glu1416del
disruptive_inframe_deletion
Exon 14 of 34ENSP00000378967.3
ATRX
ENST00000480283.5
TSL:1
n.*3987_*3989delGGA
non_coding_transcript_exon
Exon 16 of 36ENSP00000480196.1

Frequencies

GnomAD3 genomes
AF:
0.0000543
AC:
6
AN:
110418
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000330
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000194
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000382
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000379
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000663
AC:
12
AN:
180870
AF XY:
0.0000604
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000289
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000491
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.0000595
AC:
65
AN:
1092190
Hom.:
0
AF XY:
0.0000557
AC XY:
20
AN XY:
358820
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26342
American (AMR)
AF:
0.0000568
AC:
2
AN:
35197
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19344
East Asian (EAS)
AF:
0.000133
AC:
4
AN:
30188
South Asian (SAS)
AF:
0.0000740
AC:
4
AN:
54047
European-Finnish (FIN)
AF:
0.0000516
AC:
2
AN:
38757
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4119
European-Non Finnish (NFE)
AF:
0.0000573
AC:
48
AN:
838259
Other (OTH)
AF:
0.0000871
AC:
4
AN:
45937
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000543
AC:
6
AN:
110418
Hom.:
0
Cov.:
21
AF XY:
0.0000306
AC XY:
1
AN XY:
32674
show subpopulations
African (AFR)
AF:
0.0000330
AC:
1
AN:
30312
American (AMR)
AF:
0.000194
AC:
2
AN:
10283
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2638
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3561
South Asian (SAS)
AF:
0.000382
AC:
1
AN:
2620
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5778
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.0000379
AC:
2
AN:
52822
Other (OTH)
AF:
0.00
AC:
0
AN:
1487
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 18, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32156473)

Alpha thalassemia-X-linked intellectual disability syndrome Benign:2
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 01, 2019
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jun 24, 2024
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.1
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782630348; hg19: chrX-76907799; API